Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Flexion Therapeutics (FLXN)

Flexion Therapeutics (FLXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Avilar Therapeutics Appoints Adam Muzikant, PhD, as Chief Business Officer

Avilar Therapeutics , a biopharmaceutical company focused on extracellular protein degradation, today announced the appointment of Adam Muzikant, PhD, as Chief Business Officer. Dr. Muzikant brings 18...

FLXN : 9.12 (-0.22%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ECHO, ACBI, HRC, FLXN; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / November 4, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Echo Global Logistics, Inc. (NASDAQ:ECHO) concerning...

ECHO : 48.24 (+0.04%)
ACBI : 32.34 (-0.09%)
HRC : 155.96 (+0.03%)
FLXN : 9.12 (-0.22%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates FTSI, UMPQ, FLXN, ADMS; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: FTS International, Inc. (NYSE:...

UMPQ : 17.66 (-1.73%)
FLXN : 9.12 (-0.22%)
ADMS : 8.22 (+0.74%)
FTSI : 26.49 (-0.15%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

ADMS : 8.22 (+0.74%)
FLXN : 9.12 (-0.22%)
AZPN : 202.10 (+0.36%)
EBMT : 12.97 (+0.23%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates FLXN, AZPN, COLB, LMRK; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Flexion Therapeutics, Inc. (NASDAQ:...

FLXN : 9.12 (-0.22%)
AZPN : 202.10 (+0.36%)
COLB : 20.17 (+2.13%)
LMRK : 16.49 (+0.30%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

ADMS : 8.22 (+0.74%)
FLXN : 9.12 (-0.22%)
AZPN : 202.10 (+0.36%)
EBMT : 12.97 (+0.23%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADMS, FLXN, ACBI, SQ; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Adamas Pharmaceuticals, Inc....

ADMS : 8.22 (+0.74%)
FLXN : 9.12 (-0.22%)
ACBI : 32.34 (-0.09%)
SQ : 69.47 (-1.18%)
FLEXION THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Flexion Therapeutics, Inc. - FLXN

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Flexion Therapeutics, Inc. (NasdaqGM: FLXN)...

FLXN : 9.12 (-0.22%)
SHAREHOLDER ALERT: WeissLaw LLP Investigates Flexion Therapeutics, Inc.

/PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Flexion...

FLXN : 9.12 (-0.22%)
PCRX : 27.21 (-0.40%)
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Flexion Therapeutics, Inc.

/PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Flexion Therapeutics, Inc. (NASDAQ: FLXN) and its board of directors...

FLXN : 9.12 (-0.22%)
PCRX : 27.21 (-0.40%)

Barchart Exclusives

This Stock Is An Undiscovered Winner of the AI Boom
Scratch the surface of AI and data centers, and underneath you'll find a massive energy hog. Electricity consumption at U.S. data centers alone is poised to triple from 2022 levels, and that may even be too conservative of an estimate. All of this is good news for utility stocks, and one name in particular. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar